Denosumab improves bone mineral density and microarchitecture and reduces bone pain in women with osteoporosis with and without glucocorticoid treatment

Osteoporosis is a key health problem in postmenopausal women with high social and economic impact. Decreased bone mineral density (BMD) and deterioration of bone microarchitecture may occur also as a result of long-term glucocorticoid treatment (GCT) of autoimmune or inflammatory conditions. Denosum...

Descripción completa

Detalles Bibliográficos
Autores principales: Petranova, Tzvetanka, Sheytanov, Ivan, Monov, Simeon, Nestorova, Rodina, Rashkov, Rasho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Article; Medical Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434053/
https://www.ncbi.nlm.nih.gov/pubmed/26019600
http://dx.doi.org/10.1080/13102818.2014.967827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4434053/
https://www.ncbi.nlm.nih.gov/pubmed/26019600
http://dx.doi.org/10.1080/13102818.2014.967827

Ejemplares similares